Table 3.
Association between adiposity indexes and insulin resistance (Maracaibo, Venezuela).
| Without IR | With IR | OR (95% CI); p∗ | OR (95% CI); p∗∗ | |||
|---|---|---|---|---|---|---|
| n | (%) | n | (%) | |||
| Lipid accumulation product | ||||||
| <23, 6 | 444 | 43, 1 | 152 | 19, 3 | 1.00 | 1.00 |
| 23, 6–51, 2 | 354 | 34, 3 | 241 | 30, 6 | 1.91 (1.37–2.65); <0.001 | 1.91 (1.27–2.88); 0.002 |
| >51, 2 | 233 | 22, 6 | 39 | 50, 1 | 5.40 (3.48–8.39); <0.001 | 6.03 (3.45–1.52); <0.001 |
|
| ||||||
| Visceral adiposity index | ||||||
| <1, 2 | 430 | 41, 7 | 158 | 20, 1 | 1.00 | 1.00 |
| 1,2–2, 2 | 337 | 32, 7 | 272 | 34, 6 | 1.34 (0.98–1.84); 0.07 | 1.35 (0.91–1.99); 0.14 |
| >2, 2 | 264 | 25, 6 | 357 | 45, 3 | 1.14 (0.76–1.72); 0.53 | 0.98 (0.58–1.65); 0.94 |
Chi-square test: LAP (176.3; p < 0.01); VAI (116.0; p < 0.01). ∗Adjusted models for gender, age, ethnic group, education level, socioeconomic status, working status, diabetes mellitus family history, alcohol intake, smoking habits, leisure-domain physical activity, and high blood pressure according to the IDF/AHA/NHLBI/WHF/IAS/IASO 2009 consensus criteria. ∗∗Adjusted similar to model 1 plus hs-C-reactive protein.